Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
12/100
Pipeline Velocity
0/100
Trial Completion Rate
71/100
Pipeline Concentration
100/100
Pipeline Freshness
35/100
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Regulatory
Bronitin Mist — LEVOPHED
Application NDA007513 (NDA)
Bronitin Mist — BRONITIN MIST
Application NDA016126 (NDA)
Bronitin Mist — MEDIHALER-EPI
Application NDA010374 (NDA)
Bronitin Mist — NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Application NDA214628 (NDA)
Bronitin Mist — NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Application NDA215700 (NDA)
Bronitin Mist — EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Application NDA218475 (NDA)
Bronitin Mist — NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Application NDA214313 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)